1623 Capital’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,700
Closed -$4.73M 57
2021
Q4
$4.73M Sell
20,700
-4,000
-16% -$880K 1.76% 30
2021
Q3
$4.78M Hold
24,700
1.87% 25
2021
Q2
$5.25M Hold
24,700
2.02% 21
2021
Q1
$5.04M Sell
24,700
-700
-3% -$138K 2.06% 22
2020
Q4
$4.62M Hold
25,400
2.2% 24
2020
Q3
$4.25M Buy
25,400
+94
+0.4% +$15.8K 2.13% 20
2020
Q2
$4.11M Buy
25,306
+6,320
+33% +$1.13M 2.86% 19
2020
Q1
$3.28M Buy
18,986
+2,763
+17% +$550K 3.24% 18
2019
Q4
$3.26M Buy
+16,223
New +$3.33M 3.1% 19

Other funds holding CME

1623 Capital's CME Position: Q1 2022 in Review

1623 Capital sold out of CME Group (CME) in Q1 2022, closing a stake of 20,700 shares — an estimated $4.73M sold.

1623 Capital first reported a position in CME in Q4 2019 and held it in 9 quarters. The position peaked at $5.25M in Q2 2021. 1,184 funds tracked by Wall St. Rank hold CME as of Q1 2022.

  • 1623 Capital reported no remaining CME Group position as of Q1 2022 after selling out during the quarter.
  • 1623 Capital sold 20,700 CME Group shares in Q1 2022, an estimated $4.73M.
  • 1623 Capital first reported a position in CME Group in Q4 2019 and held it in 9 quarters.
  • 1623 Capital's CME Group position peaked at $5.25M in Q2 2021.
  • 1,184 funds tracked by Wall St. Rank held CME Group as of Q1 2022.

Based on 1623 Capital's 13F filing for Q1 2022, filed 13 May 2022.